ReviewCurrent cardiology reports2023
Fibrates, Hypertriglyceridemia, and CVD Risk: Where Do We Stand After the PROMINENT Trial for Triglyceride Lowering?
Marius I Chukwurah et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papertrialcites it